Exagen inc. to participate in the 2023 cantor fitzgerald global healthcare conference

San diego, california, sept. 12, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 cantor fitzgerald global healthcare conference, which takes place september 26-28, 2023, at the intercontinental barclay hotel in new york city. john aballi, exagen's president and chief executive officer and kamal adawi, exagen's chief financial officer, will participate in a panel discussion on tuesday, september 26th, at 8:45 am et. interested parties may access the webcast of the presentation using a link on exagen's website at https://investors.exagen.com/events.
XGN Ratings Summary
XGN Quant Ranking